Reduced expression of interleukin-8 receptors A and B on polymorphonuclear neutrophils from persons with human immunodeficiency virus type 1 disease and pulmonary tuberculosis

The Journal of Infectious Diseases
S Meddows-TaylorC T Tiemessen

Abstract

The expression of the two human interleukin (IL)-8 receptors, designated IL-8RA (CXCR-1) and IL-8RB (CXCR-2), on the surface of whole blood polymorphonuclear leukocytes (PMNL) was determined by use of receptor-specific monoclonal antibodies and flow cytometry. Sixteen subjects each were included in 4 study groups: healthy blood donors (ND), patients with pulmonary tuberculosis (TB), human immunodeficiency virus type 1-seropositive patients (HIV), and HIV-1-seropositive subjects with pulmonary tuberculosis (HIV/TB). A significant reduction in the percentage of PMNL expressing IL-8RA and IL-8RB and in their respective fluorescence intensities was found in TB, HIV, and HIV/TB groups compared with that obtained for the ND group. The greatest down-regulation of both receptors occurred in the HIV/TB group. Furthermore, associated with this reduced expression of IL-8 receptors was impairment of both intracellular calcium flux and migration of PMNL in response to IL-8 in a group of HIV/TB patients compared with that in healthy persons.

Citations

Apr 20, 2001·Cytokine & Growth Factor Reviews·Y LeJ M Wang
Jun 6, 2012·AIDS Research and Treatment·Pichili Vijaya Bhaskar ReddyMadhavan P N Nair
Mar 16, 2007·Proceedings of the National Academy of Sciences of the United States of America·A VasilescuF Matsuda
Dec 3, 2014·The Lancet Infectious Diseases·Michaëla A M HusonTom van der Poll
Sep 1, 2015·Tuberculosis·Nader AlaridahGabriela Godaly
Apr 3, 2004·Pediatric Allergy and Immunology : Official Publication of the European Society of Pediatric Allergy and Immunology·Stephen Meddows-Taylor, Caroline T Tiemessen
Dec 20, 2008·Journal of Internal Medicine·L PiacentiniM Clerici
Aug 31, 2000·Clinical Immunology : the Official Journal of the Clinical Immunology Society·Y LeJ Ming Wang
Feb 23, 2008·Arteriosclerosis, Thrombosis, and Vascular Biology·Elena RigamontiGiulia Chinetti-Gbaguidi
Jun 28, 2001·Clinical and Diagnostic Laboratory Immunology·C T TiemessenD J Martin
Apr 4, 2014·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Ann-Kathrin HoffmannStefan Linder
Sep 24, 2002·The Journal of Immunology : Official Journal of the American Association of Immunologists·Supriya D MahajanMadhavan P N Nair
Oct 22, 2003·The Journal of Immunology : Official Journal of the American Association of Immunologists·Paul KubesChristopher Power
Oct 9, 2002·The Journal of Immunology : Official Journal of the American Association of Immunologists·Amato de PaulisGianni Marone
Sep 8, 1998·Clinical and Diagnostic Laboratory Immunology·S ShalekoffC T Tiemessen

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antitubercular Agents (ASM)

Antitubercular agents are pharmacologic agents for treatment of tuberculosis. Discover the latest research on antitubercular agents here.

Antitubercular Agents

Antitubercular agents are pharmacologic agents for treatment of tuberculosis. Discover the latest research on antitubercular agents here.

Cell Migration

Cell migration is involved in a variety of physiological and pathological processes such as embryonic development, cancer metastasis, blood vessel formation and remoulding, tissue regeneration, immune surveillance and inflammation. Here is the latest research.